Misoprostol (known substance with new data exclusivity: labour induction)

Subject:

• Active Substance: Misoprostol
• Name: Angusta^®
• Therapeutic area: Labour induction
• Pharmaceutical company: Norgine GmbH

Time table:

• Start: 01.09.2021
• Final decision by G-BA: 17.02.2022

Final decision:

• No additional benefit proved